Dr. Hadley Stevens Smith is a health economist and a scholar of the ethical, legal, and social implications (ELSI) of genomics. She studies clinical, patient-centered, and economic outcomes of genomic medicine, primarily for newborn and pediatric patient populations. The goal of her research program is to inform efficient and ethical implementation of genomic technologies into clinical care.
Dr. Smith uses both qualitative and quantitative research methods. She has expertise in survey-based research to measure patient-centered outcomes and preferences as well as electronic health record-based research and cost-effectiveness analysis. Much of her work has focused on development and application of tools to measure the utility of genomic sequencing and assessment of family-level impacts of genetic conditions and genomic sequencing on health care utilization, costs, and well-being. In addition to methodological issues, she is interested in normative aspects of value assessment and payer decision-making. Dr. Smith received a K99/R00 career development award from the National Human Genome Research Institute (NHGRI) to study the family-level utility of pediatric genomic sequencing using a patient-centered approach and decision science methods.
Dr. Smith completed a BS in Political Science with a minor in Genetics at Texas A&M University. She received a Master of Public Service and Administration with a concentration in Health Policy Analysis from the Bush School of Government and Public Service at Texas A&M University. She earned her PhD in Public Health (Health Economics track) at the University of Texas Health Science Center at Houston. After completing her PhD, Dr. Smith was a Health Policy Fellow in the Center for Medical Ethics and Health Policy at Baylor College of Medicine where she contributed to several high-profile NIH-funded genomics research efforts, including the Clinical Sequencing Evidence Generating Research Consortium (CSER).